Pharmaceutical companies including Novartis and Roche have teamed up with global cancer organizations in an alliance aimed at getting more oncology medications to poorer countries.
Several generic drugmakers that will produce versions of Pfizer’s COVID-19 antiviral treatment Paxlovid agreed to sell the medicine in low-income and middle-income countries for $25 a course or less, the Clinton Health Access Initiative (CHAI) said on May 12.
The Rockefeller Foundation announced the launch of the Global Vaccination Initiative, a $55 million investment over two years to support country-led efforts to fully vaccinate 90% of the most at-risk populations in Africa, Asia, Latin America, and the Caribbean.
Three Lakes Foundation and the American College of Chest Physicians (CHEST) recently announced their collaboration on a multiphase educational initiative aiming to reduce the time it takes to diagnose patients with Interstitial Lung Diseases (ILD).
President Joe Biden on Feb. 2 announced plans to reduce the death rate from cancer by at least 50 percent over the next 25 years, part of an effort to revive the “Cancer Moonshot” initiative to speed research and make more treatments available.
The U.S. Department of Health and Human Services (HHS) appears unprepared to assume full responsibility for the nation’s Covid-19 vaccine program, including activities currently managed by the Pentagon, according to a draft government watchdog report reviewed by Reuters.
As Covid-19 infections driven by the Delta variant continue to spike across much of the United States, stretching health care services to the limits, the White House is seeking $65 billion to lay the groundwork for future pandemic preparedness.
In a survey released by oncology data leader COTA, half of the respondents pointed to “Operation Warp Speed” for the Covid-19 pandemic as the seed of their belief that cancer treatments can and should be moving forward faster.
Inovio Pharmaceuticals said on April 23 the U.S. government had stopped funding for a late-stage study testing the company’s Covid-19 vaccine candidate, due to the increasing availability of authorized shots in the country.
Face2Face America, a nationwide, community-driven Covid-19 vaccine education initiative, launched a call to action to engage other members of the healthcare communications industry to lend support to their initiative to fight vaccine hesitancy.